Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -369.11x is 73% below its 5-year average of -212.76x, around the middle of its 5-year range (-1197.30x–-11.76x).
10.45% below its 12-month average of -334.20x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-07-31): -182.73x.
INTEREST COVERAGE RATIO
-369.11x
INTEREST COVERAGE RATIO AVG TTM
-334.20x
INTEREST COVERAGE RATIO AVG 3Y
-231.65x
INTEREST COVERAGE RATIO AVG 5Y
-212.76x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.45%
CURRENT VS 3Y AVG
-59.34%
CURRENT VS 5Y AVG
-73.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-5631.52%
vs the sector median at left
Nutriband Inc.
Market Cap
$81.20M
Interest Coverage Ratio
-369.11x
TTM Avg
-334.20x
3Y Avg
-231.65x
5Y Avg
-212.76x
Market Cap
$82.47M
Interest Coverage Ratio
N/A
TTM Avg
26.56x
3Y Avg
26.56x
5Y Avg
26.56x
Market Cap
$82.53M
Interest Coverage Ratio
N/A
TTM Avg
2.82x
3Y Avg
2.82x
5Y Avg
2.82x
Market Cap
$82.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.03M
Interest Coverage Ratio
-107.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $81.20M | -369.11x | -334.20x | -231.65x | -212.76x |
| MediciNova, Inc. (MNOV)vs › | $81.22M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -9.55x | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.29M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | N/A | 26.56x | 26.56x | 26.56x |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | N/A | 2.82x | 2.82x | 2.82x |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -107.89x | N/A | N/A | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -5468.00x | N/A | N/A | N/A |
Interest Coverage
-369.1x
Debt/Equity
0.04
Current Ratio
4.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-31 | -182.73x |
| 2026-04-30 | -250.47x |
| 2026-01-31 | -191.40x |
| 2025-10-31 | -699.41x |
| 2025-07-31 | -347.00x |
| 2025-04-30 | -240.39x |
| 2025-01-31 | -525.27x |
| 2024-10-31 | -354.01x |
| 2024-07-31 | -280.93x |
| 2024-04-30 | -219.25x |
| 2024-01-31 | -56.27x |
| 2023-10-31 | -42.87x |
| 2023-07-31 | -89.25x |
| 2023-04-30 | -321.50x |
| 2022-10-31 | -270.18x |
| 2022-07-31 | -233.52x |
| 2022-04-30 | -166.88x |
| 2022-01-31 | -1197.30x |
| 2021-10-31 | -46.09x |
| 2021-07-31 | -11.76x |
| 2021-04-30 | -7.71x |
| 2021-01-31 | -29.54x |
| 2020-10-31 | -25.31x |
| 2020-07-31 | -4427.80x |
| 2020-04-30 | -0.72x |
| 2020-01-31 | -8.57x |
| 2019-10-31 | -798.49x |
| 2019-07-31 | -471.79x |
| 2019-04-30 | -2985.21x |
